Seizert Capital Partners LLC Has $45.64 Million Holdings in Amdocs Limited (NASDAQ:DOX)

Seizert Capital Partners LLC lifted its stake in shares of Amdocs Limited (NASDAQ:DOX) by 9.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 536,074 shares of the technology company’s stock after buying an additional 45,419 shares during the period. Amdocs comprises approximately 2.1% of Seizert Capital Partners LLC’s investment portfolio, making the stock its 19th biggest position. Seizert Capital Partners LLC owned approximately 0.47% of Amdocs worth $45,641,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of the stock. First Horizon Advisors Inc. grew its stake in shares of Amdocs by 1.9% in the third quarter. First Horizon Advisors Inc. now owns 5,902 shares of the technology company’s stock worth $516,000 after purchasing an additional 109 shares during the last quarter. Private Trust Co. NA grew its stake in shares of Amdocs by 62.9% in the third quarter. Private Trust Co. NA now owns 303 shares of the technology company’s stock worth $27,000 after purchasing an additional 117 shares during the last quarter. Principal Securities Inc. grew its stake in shares of Amdocs by 10.4% in the fourth quarter. Principal Securities Inc. now owns 1,341 shares of the technology company’s stock worth $114,000 after purchasing an additional 126 shares during the last quarter. Morton Community Bank grew its stake in shares of Amdocs by 0.4% in the third quarter. Morton Community Bank now owns 36,410 shares of the technology company’s stock worth $3,185,000 after purchasing an additional 130 shares during the last quarter. Finally, Private Advisor Group LLC grew its stake in shares of Amdocs by 3.2% in the third quarter. Private Advisor Group LLC now owns 5,626 shares of the technology company’s stock worth $492,000 after purchasing an additional 175 shares during the last quarter. 92.02% of the stock is currently owned by institutional investors and hedge funds.

Amdocs Trading Down 0.4 %

DOX opened at $86.48 on Wednesday. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.16 and a quick ratio of 1.20. Amdocs Limited has a fifty-two week low of $74.41 and a fifty-two week high of $94.04. The firm has a market capitalization of $9.76 billion, a PE ratio of 20.06, a P/E/G ratio of 1.47 and a beta of 0.71. The company’s 50-day moving average is $86.21 and its 200 day moving average is $86.88.

Amdocs (NASDAQ:DOX) last posted its earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share for the quarter, missing analysts’ consensus estimates of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. As a group, research analysts predict that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Monday, March 31st will be issued a $0.527 dividend. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.44%. The ex-dividend date is Monday, March 31st. This is a positive change from Amdocs’s previous quarterly dividend of $0.48. Amdocs’s dividend payout ratio is currently 48.72%.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Oppenheimer upped their price target on shares of Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. Barclays cut their price target on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a research report on Thursday, November 14th. Finally, StockNews.com cut shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, Amdocs presently has a consensus rating of “Moderate Buy” and a consensus target price of $101.20.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.